where to be online

10+ can't-miss virtual business and innovation events in Houston for July

A Rice University course on fostering innovation at your company, investor Q&As, a summit for drone and robotics within the energy industry, and more online events not to miss this month. Getty Images

Virtual events at this point has become the new normal for Houston's innovation ecosystem. From interactive Q&As and virtual pitches to online courses and panels, here's what's in store for Houston entrepreneurs this month.

July 1 — The Ion Smart and Resilient Cities Accelerator Cohort 2 Demo Day

The Ion Smart and Resilient Cities Accelerator Cohort 2's Demo Day will be filled with sessions that speak to Cohort 2's themes of air quality, water purification, and cleantech efforts in Houston. These sessions will feature the work that is currently being done, and highlight the work that needs to be done.

Details: This event takes place Wednesday, July 1, from 9 a.m. to 5 p.m. Learn more.

July 8 — HXTV'S HouTech Talks ft. AvidXchange

Tyler Gill and Chris Elmore of AvidXchange join HXTV for a live Q&A that will tackle the big questions on everyone's mind, like how founders should adjust in the face of the pandemic and what fundraising will look like once the pandemic loosens its grip.

Details: This event takes place Wednesday, July 8, from 1 to 2 pm. Learn more.

July 9 — Intro to Investing & Ask Me Anything with Dumb Money and Joshua Baer

Join Capital Factory as they walk you through the ins and outs of investing in startups, stocks, and more with guest speakers from Dumb Money.


Details: This event takes place Thursday, July 9, from 2 to 3:30 pm.Learn more.

July 11 — Enventure Basecamp: Business Building Workshop

Enventure's community-driven business building basecamp series returns this June to support a local innovator construct their healthcare venture. This month, BioVentures team DiaPacer is featured.

Details: This event takes place Saturday, July 11, from 9 a.m. to noon. Learn more.

July 14 — HXTV's VC Ask Me Anything Virtual Event featuring Plug and Play

In this virtual event, Neda Amidi, Milad Malek, and Payal Patel will share information about Plug and Play's investment activities and other plans in Houston.

Details: This event takes place Tuesday, July 14, from 5 to 6 p.m. Learn more.

July 14-16 — Energy Drone & Robotics Virtual Summer Summit

Ahead of its fall summit, Energy Drone & Robotics is bringing live industry keynotes, asset owner panels, moderated discussion groups, 1:1 meetings, demos and use cases with hardware, software and service solution providers virtually.

Details: This event takes place Tuesday, July 14, to Thursday, July 16. Learn more.

July 15 — Maintaining an Ecosystem in a Time of Uncertainty

At this event, General Assembly is hosting local leaders to discuss how they are coping with the COVID-19 devastation and what they're doing to maintain community and interaction within their groups.

Details: This event takes place Wednesday, July 15, from 6 to 7:30 p.m.Learn more.

July 16 — HXTV's VC Ask Me Anything Virtual Event featuring Bowery Capital

Bowery Capital is an early-stage venture capital investor focused exclusively on founders looking to modernize business through technology. The live Q&A that will tackle the big questions on everyone's mind, like how founders should adjust in the face of the pandemic and what fundraising will look like once the pandemic loosens its grip.

Details: This event takes place Thursday, July 16, from 3 to 4 pm. Learn more.

July 16-17 — MassChallenge's Virtual Showcase

Hear from all 56 startups in the Houston cohort as well as the Boston, Austin, and Rhode Island cohorts. The showcase environment is a premier opportunity for hear directly from the founding teams and get a sneak peek at the future of business and technology. At the center of the event will be the startup demo booths where each company will actively pitch their mission and business to event guests.

Details: This event takes place Thursday, July 16, to Friday, July 17, from noon to 3 p.m. Learn more.

July 17 — Open Innovation and Problem-Solving in an Organization

Open innovation enables firms to leverage data, talent and expertise to rapidly generate new ideas, solve problems and find efficiencies. This Rice University course will help business leaders identify urgent and critical problems amenable to open innovation solutions and develop creative strategies and implementation through open innovation.

Details: This event takes place Friday, July 17, from 9 to 11 a.m. Learn more.

July 29 — Transition into Tech (For Oil and Gas Professionals)

What happens when you've realized it's time for a change? For many, it can be as simple as a new look, a new restaurant, or a trip out of town. But what about when it's your career and livelihood that needs to be revamped? This can happen for any number of reasons, but the challenges and questions remain the same - what's next and how do I get there?

Details: This event takes place Wednesday, July 29, from 6 to 7:30 p.m.Learn more.

Trending News

 
 

Promoted

Emerson Perin of the Texas Heart Institute, recently published the largest clinical trial of cell therapy for patients with chronic heart failure to-date included 580 patients at 52 sites throughout North America. Photo via texasheart.org

Emerson Perin’s end goal isn’t to treat heart failure. The medical director of The Texas Heart Institute says that he has his sights set firmly on curing the malady altogether. And, with the power of innovation and a strong team, the Houston-based cardiologist has a good chance of meeting his objective.

Perin first came to THI for fellowship training in 1988, following his residency in Miami and medical school in his birthplace of Brazil.

“This is a very special place,” the physician and researcher, whose titles also include director for THI’s Center for Clinical Research and vice president for medical affairs, tells InnovationMap. “It has a worldwide-reaching reputation. I’ve always liked research and this is a great place in terms of innovation and practicing high-level cardiology.”

For decades, Perin has followed in THI founder Denton Cooley’s footsteps with world-changing research. In 2001, the founding medical director of THI’s Stem Cell Center was the first person to inject stem cells into a failing human heart. It led to a trial of 17 patients that year.

“A couple of the patients did remarkably well — more than you could ever expect. These guys who couldn’t’ walk across the room pretty much were jogging on the beach. That gave me the initial insight that this works,” Perin recalls.

What exactly is heart failure? The term refers to the condition of a heart that can’t pump enough blood to sustainably power the body through oxygenation of the tissues from blood flow. It may sound like a death sentence, but with appropriate care, it can usually be managed with medicines and if worsening occurs, devices and, ultimately, heart transplantation.

And Perin is proving that there’s a lot of life ahead for heart failure patients. Earlier this year, he published another groundbreaking clinical trial, DREAM-HF. The largest clinical trial of cell therapy for patients with chronic heart failure to-date included 580 patients at 52 sites throughout North America.

With the goal of getting a new cell therapy approved for heart failure, the primary endpoint was to prove that the therapy could prevent recurrent hospitalizations.

“It was a total negative,” says Perin. That’s because the cells don’t have a decongestant effect such as the medicines currently used to treat heart failure.

But that doesn’t mean that the trial was a failure. Quite the opposite. That’s because Perin and his team proved something else: The trial was able to prove that there was significant improvement in patients with inflammation. After those patients were injected with mesenchymal precursor cells (MPC), they showed a 70-percent reduction in heart attacks and strokes. Cardiovascular deaths also decreased.

These are blockbuster numbers, and big news for patients dealing with heart failure. What it means is that the cells addressed a different aspect of heart failure that until now had been left untreated which was the inflammation — how heart failure starts and what keeps it going.

So what’s next? Going to the FDA.

“They said, ‘We can’t approve it with one trial, but we’ll approve it with two,’” says Perin.

This time, his primary endpoint will be tailored to suit the positive outcome he knows he’ll be able achieve. This next round will begin in 2024.

Once the FDA approves a new catheter system for injecting the heart with stem cells and genes, the team will proceed with new studies. Gene therapy will be another frontier for Perin — and patients with heart failure.

“I think the combination of cells and genes is even more powerful,” he says. “That will help save lives in a completely new way and do away with heart failure.”

Perin's work is just one piece of the puzzle, and Dr. Joseph Rogers, who was appointed president and CEO of THI in 2021, is leading the organization's initiative in several ways. THI, recently buoyed by a $32 million donation from a patient — the largest charitable donation in its history — is exploring several innovative therapeutics, devices, and treatments.

THI recently received a two-year, $1.14 million grant from The National Heart, Lung, and Blood Institute to develop a novel, first-in-class drug to treat the cardiovascular disease that arises from atherosclerosis. Another THI innovator, Camila Hochman-Mendez — along with her research team — is studying the effects of regenerative medicine on hearts.

Trending News

 
 

Promoted